PDCD1 and neoplasm: Using a murine melanoma model, Daneshmandi S. et al. [116] demonstrated that the blockage of LDHA increased the number and cytolytic activity of NK cells and cytotoxic T lymphocytes, resulting in reduced tumor growth, when initiated in combination with anti-PD-1 therapy [116].